Cetera Advisors’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,429
Closed -$173K 1705
2023
Q1
$173K Buy
18,429
+859
+5% +$9.48K ﹤0.01% 1511
2022
Q4
$205K Buy
+17,570
New +$194K ﹤0.01% 1430

Other funds holding HHS

Cetera Advisors's HHS Position: Q2 2023 in Review

Cetera Advisors sold out of Harte-Hanks (HHS) in Q2 2023, closing a stake of 18,429 shares — an estimated $173K sold.

Cetera Advisors first reported a position in HHS in Q4 2022 and held it in 2 quarters. The position peaked at $205K in Q4 2022. 30 funds tracked by Wall St. Rank hold HHS as of Q2 2023.

  • Cetera Advisors reported no remaining Harte-Hanks position as of Q2 2023 after selling out during the quarter.
  • Cetera Advisors sold 18,429 Harte-Hanks shares in Q2 2023, an estimated $173K.
  • Cetera Advisors first reported a position in Harte-Hanks in Q4 2022 and held it in 2 quarters.
  • Cetera Advisors's Harte-Hanks position peaked at $205K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2023.

Based on Cetera Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.